Shilpa Medicare Limited

Web: vbshilpa.com NSE: SHILPAMED BSE: 530549 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

964 8(1%)

Near 52W High of 974

Volume

42L as on 23, Jun

Open

780

High

786

Low

773

956

VWAP

579

52 Week High

974

52 Week Low

260

Viand Research Rating

Quality Score

72/100

Growth Score

76/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

18,878

No. of Shares

19.6

P/E

122.78

P/B

3.25

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

2.65

ROCE

Profit Growth

Listing Date

03-Dec-09

Promoter Holding

40.13%

FII Holding

11.07%

DII Holding

8.58%

Price Chart

Price Performance

1 Week7%

1 Month21%

3 Months89%

6 Months75%

1 Year75%

YTD75%

Moving Average

5 Day SMA562

10 Day SMA554

20 Day SMA537

30 Day SMA515

50 Day SMA477

61 Day SMA457

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	568	551	562	568
Resistance 2	562	550	557	562
Resistance 1	555	549	554	555
Pivot Point	549	548	549	549
Support 1	542	547	544	543
Support 2	537	546	541	537
Support 3	530	544	537	530

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 40.13%	(-4.11) 40.13%	(0.01) 44.23%	(0.01) 44.23%	(0.01) 44.23%	(-0.11) 44.23%	(-0.11) 44.33%	(-5.61) 44.39%	(0.01) 50.01%	(0.01) 50.01%	(0.01) 50.01%	(0.01) 50.01%	(0.01) 50.01%	(0.01) 50.01%	(0.01) 50.01%	(0.01) 50.01%	(0.01) 50.01%	(-3.21) 50.01%	(0.01) 53.25%
FIIs	(0.11) 11.07%	(0.11) 10.97%	(-0.31) 10.92%	(0.21) 11.19%	(1.11) 10.97%	(0.31) 9.90%	(0.51) 9.59%	(3.51) 9.08%	(-2.91) 5.63%	(-0.11) 8.52%	(-1.71) 8.60%	(-3.51) 10.26%	(-1.61) 13.73%	(0.91) 15.32%	(0.11) 14.46%	(0.01) 14.41%	(-0.21) 14.41%	(2.31) 14.59%	(0.01) 12.27%
DIIs	(0.21) 8.58%	(0.71) 8.34%	(0.21) 7.67%	(-0.11) 7.46%	(-0.71) 7.55%	(0.11) 8.27%	(0.61) 8.18%	(6.01) 7.61%	(1.61) 1.65%	(-0.41) 0.06%	(0.01) 0.41%	(-0.21) 0.37%	(-0.11) 0.54%	(-1.21) 0.61%	(-0.21) 1.76%	(0.11) 1.99%	(-0.91) 1.93%	(-0.11) 2.86%	(0.01) 2.91%
Public	40.21%	40.56%	37.18%	37.10%	37.25%	37.59%	37.90%	38.91%	42.71%	41.41%	40.98%	39.36%	35.72%	34.04%	33.78%	33.59%	33.65%	32.54%	31.57%
No. of Shareholders	53,410	53,799	52,065	48,636	50,108	49,034	42,784	41,072	46,046	43,630	44,094	50,434	46,869	46,143	41,579	39,097	39,724	39,565	46,540

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	437	410	370	321	331	319	344	293	292	287	313	260	264	262	263	261	341	272	295	237
Sales Growth % (YoY)	32.1%	28.5%	7.6%	9.9%	13.4%	11.4%	9.8%	12.4%	10.7%	9.2%	19%	-0.4%	-22.6%	-3.6%	-11%	10%	63.7%	42.4%	5.8%	6.5%
Sales Growth % (QoQ)	6.6%	10.8%	15.3%	-3%	3.8%	-7.3%	17.4%	0.3%	1.7%	-8.3%	20.4%	-1.5%	0.8%	-0.4%	0.8%	-23.5%	25.4%	-7.8%	24.5%	-
Expenses	317	296	262	231	252	239	258	222	222	222	255	214	227	231	253	241	268	228	243	206
Operating Profit	120	114	108	91	79	81	86	70	70	65	58	46	37	31	10	20	73	44	52	31
OPM %	27	28	29	28	24	25	25	24	24	23	19	18	14	12	4	8	21	16	18	13
Other Income	45	-13	2	6	-21	2	5	10	9	2	2	2	2	3	4	8	5	5	10	2
Interest	14	11	16	19	14	12	26	24	24	26	23	18	18	18	13	10	9	10	12	10
Depreciation	31	30	30	29	29	29	28	27	27	27	28	27	26	24	23	22	22	21	19	18
Profit before tax	120	61	64	50	15	42	37	29	28	14	9	3	-4	-8	-22	-4	46	19	31	5
Tax %	10	27	32	5	5	24	51	51	12	67	83	64	90	-13	-17	-158	36	50	37	69
Net Profit	108	45	44	47	15	32	18	14	24	5	2	1	-8	-7	-19	2	30	10	20	2
Net Profit Growth % (QoQ)	140%	2.3%	-6.4%	213.3%	-53.1%	77.8%	28.6%	-41.7%	380%	150%	100%	112.5%	-14.3%	63.2%	-1050%	-93.3%	200%	-50%	900%	-
Net Profit Growth % (YoY)	620%	40.6%	144.4%	235.7%	-37.5%	540%	800%	1300%	400%	171.4%	110.5%	-50%	-126.7%	-170%	-195%	-	-	-	-	-
TTM Net Profit	244	151	138	112	79	88	61	45	32	0	-12	-33	-32	6	23	62	62	32	22	0
EPS in Rs	5.51	2.28	2.25	2.4	0.74	1.62	0.92	0.72	1.41	0.26	0.09	0.07	-0.46	-0.38	-1.07	0.05	3.4	1.1	2.45	0.2

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	1539	1281	1146	1046	1141	899	908	733	789	779	719	614	571	371
Sales Growth %	20.2%	11.8%	9.5%	-8.4%	27%	-1%	23.8%	-7%	1.2%	8.3%	17.2%	7.4%	54%	16.6%
Expenses	1104	965	907	947	940	718	688	585	634	614	566	485	455	301
Operating Profit	435	316	239	99	202	181	219	148	155	165	153	129	116	70
OPM %	28	25	21	9	18	20	24	20	20	21	21	21	20	19
Other Income	39	-5	15	17	21	90	17	33	22	15	5	5	6	5
Interest	59	76	92	59	41	22	5	4	3	3	7	4	4	2
Depreciation	120	113	108	96	80	54	44	42	37	31	29	21	23	15
Profit before tax	295	122	54	-38	102	195	188	136	137	146	122	108	95	57
Tax %	18	36	41	-19	41	25	18	19	25	29	19	33	21	17
Net Profit	243	78	32	-31	61	146	155	110	103	104	99	73	75	47
Net Profit Growth %	211.5%	143.8%	203.2%	-150.8%	-58.2%	-5.8%	40.9%	6.8%	-1%	5.1%	35.6%	-2.7%	59.6%	-
EPS in Rs	12.44	4	1.84	-1.87	3.49	9.06	9.57	6.88	6.45	6.71	6.73	4.78	5.14	6.44
Dividend Payout %	5	12	0	0	16	6	6	7	5	4	4	6	5	7

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	342	132	137	180	105	47	124	147	45	37	129	69	70	44
Cash from Investing Activity	-326	-198	-171	-232	-286	-404	-290	-196	-10	-257	-106	-196	-49	-95
Cash from Financing Activity	14	63	47	46	83	436	176	10	-61	313	-20	136	-28	66
Net Cash Flow	30	-3	13	-7	-98	79	10	-39	-26	93	3	9	-8	15

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	20	10	10	10	9	9	9	8	8	8	8	8	8	8	7	5
Reserves	2572	2427	2362	2318	1800	1775	1814	1471	1321	1189	1077	979	639	539	389	316
Borrowings	660	593	588	491	937	798	683	846	390	194	191	241	221	189	118	132
Other Liabilities	455	465	351	299	347	323	370	308	270	218	223	244	194	169	163	99
Total Liabilities	3706	3495	3311	3117	3093	2904	2876	2632	1989	1610	1499	1472	1062	905	678	551
Fixed Assets	2046	1801	1418	1693	1385	1368	1342	1111	650	558	534	492	580	316	294	181
CWIP	431	534	822	455	719	655	506	541	666	429	210	141	95	222	111	129
Investments	58	32	35	36	40	43	34	21	10	2	140	253	53	66	10	50
Other Assets	1170	1128	1037	933	950	838	993	959	662	621	615	587	334	301	262	191
Total Assets	3706	3495	3311	3117	3093	2904	2876	2632	1989	1610	1499	1472	1062	905	678	551

Delivery

Delivery Data: SHILPAMED

#	Date	557 75% 974	Value (Cr)	Q/T 37	Del 33	Del 99
1	4-Sep	964	63	27	38	24
2	3-Sep	956	178	26	42	74
3	2-Sep	929	135	31	43	57
4	1-Sep	890	201	28	38	76
5	31-Aug	949	240	41	38	92
6	28-Aug	904	79	27	45	35
7	27-Aug	902	201	44	46	92
8	26-Aug	861	63	22	41	26
9	25-Aug	862	102	28	28	28
10	24-Aug	856	255	32	29	75
11	21-Aug	815	58	27	49	28
12	20-Aug	821	108	31	45	49
13	19-Aug	808	50	23	49	24
14	18-Aug	810	49	25	54	27
15	17-Aug	809	61	24	44	27
16	14-Aug	822	85	32	50	42
17	13-Aug	807	110	27	39	43
18	12-Aug	805	79	30	41	32
19	11-Aug	820	198	31	34	68
20	10-Aug	808	507	53	27	137
21	7-Aug	760	476	48	13	60
22	6-Aug	739	1574	52	12	190
23	5-Aug	722	1186	50	13	154
24	4-Aug	645	93	35	44	41
25	3-Aug	624	30	28	51	15
26	31-Jul	611	30	30	52	15
27	30-Jul	603	15	25	53	8
28	29-Jul	605	23	21	46	11
29	28-Jul	605	26	27	47	12
30	27-Jul	621	19	21	43	8
31	24-Jul	606	26	25	37	10
32	23-Jul	604	29	26	47	14
33	22-Jul	613	34	23	45	15
34	21-Jul	640	32	32	49	16
35	20-Jul	625	26	23	48	13
36	17-Jul	620	30	22	51	15
37	16-Jul	638	25	23	43	11
38	15-Jul	646	47	34	50	24
39	14-Jul	624	61	37	51	31
40	13-Jul	630	24	28	50	12
41	10-Jul	627	38	28	47	18
42	9-Jul	622	83	31	42	35
43	8-Jul	595	42	25	45	19
44	7-Jul	600	24	21	43	10
45	6-Jul	597	36	33	45	16
46	3-Jul	609	78	37	46	36
47	2-Jul	601	106	45	42	44
48	1-Jul	571	113	50	41	46
49	30-Jun	598	214	45	36	77
50	29-Jun	574	77	39	50	39

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	18,878c	89c	0.47
03-Sep	18,789c	1,212c	6.89
01-Sep	17,577c	848c	4.60
31-Aug	18,425c	1,572c	9.32
26-Aug	16,853c	491c	3.00
25-Aug	16,362c	438c	2.61
24-Aug	16,801c	777c	4.85
21-Aug	16,023c	201c	1.27
19-Aug	15,823c	49c	0.31
18-Aug	15,872c	49c	0.31
17-Aug	15,823c	264c	1.64
14-Aug	16,087c	538c	3.46
13-Aug	15,549c	169c	1.08
12-Aug	15,718c	292c	1.83
11-Aug	16,010c	207c	1.31
10-Aug	15,803c	1,145c	7.81
06-Aug	14,658c	2,082c	16.56
05-Aug	12,576c	16c	0.12
04-Aug	12,592c	583c	4.85
31-Jul	12,009c	94c	0.79
30-Jul	11,915c	133c	1.13
29-Jul	11,782c	34c	0.29
28-Jul	11,816c	369c	3.03
27-Jul	12,185c	0	0

Stock Checklist

Price is above from 52 week high low average: 99%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: YES

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 46 fund scheme(s) across 11 fund house(s) as of Aug26 · Total value ₹982 Cr · 16 increasing / 8 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Bandhan Mutual Fund	8	0.50%	+0.12%	285.3
ICICI Prudential Mutual Fund	4	0.89%	-	281.4
Aditya Birla Sun Life Mutual Fund	8	0.96%	+0.05%	167.4
HDFC Mutual Fund	2	2.25%	-0.23%	132.1
WhiteOak Capital Mutual Fund	10	0.21%	+0.03%	70.4
Motilal Oswal Mutual Fund	4	0.77%	+0.20%	38
ITI Mutual Fund	2	1.15%	-0.03%	6.1
Samco Mutual Fund	2	0.26%	-	0.8
Groww Mutual Fund	2	0.04%	+0.01%	0.3
Angel One Mutual Fund	2	0.03%	+0.01%	0
Mirae Asset Mutual Fund	2	0.04%	+0.01%	0

Shilpa Medicare Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements